Skip to content

Effectiveness of FACoT for Individuals Post Stroke

Effectiveness of a Novel Meta-cognitive-functional Intervention (FACoT) for Individuals Post Mild-moderate Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02925637
Enrollment
66
Registered
2016-10-06
Start date
2017-03-12
Completion date
2020-02-27
Last updated
2021-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

To develop and assess the effectiveness of a novel cognitive-functional intervention (FACoT) in occupational therapy for people after mild to moderate stroke.

Interventions

OTHERFaCoT

The intervention will include: functional activities, cognitive activities and strategies (pencil-pen treatment), and behavioural strategies

Sponsors

Tel Aviv University
CollaboratorOTHER
Bait Balev Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \>18 years * at least three years post stroke * severity mild to moderate (NIHSS≤5) * independent prior to the stroke * can understand and speak Hebrew

Exclusion criteria

* with no other neurological or psychiatric conditions * without dementia

Design outcomes

Primary

MeasureTime frame
Change in scores of The Canadian Occupational Performance Measure (COPM)Change between baseline (week 0) to time 1 (post-intervention -10-13 weeks later) and time 2 (follow-up- three month later)

Secondary

MeasureTime frame
Change in scores of Patient competency rating scale (PCRS)Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later)
Change in scores of zoo-mapChange between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up-3 month later)
Change in scores of Dysexecutive Questionnaire (DEX)Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3month later)
Geriatric Depression Scale - short form (GDS-SF)Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later)
Change in scores of the Instrumental Activities of Daily Living (IADL) scaleChange between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later)
Change in scores of Reintegration to Normal Living Index (RNL)Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up-3 month later)
Change in scores of Short Form-12v2 Health Survey (SF-12v2)Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later)
change in scoe of New general self efficacy scale (NGSE)Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later)
Change in scores Self Regulation Skills Interview (SRSI)Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later)
Change in scores of Montreal Cognitive Assessment (MoCA)Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up-3 month later)
Change in scores of Trail making test (TMT)Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later)

Other

MeasureTime frame
demographic questionnairebaseline (week 0)
National Institutes of Health Stroke Scale (NIHSS)baseline (week 0)
Functional Independence Measure (FIM)baseline (week 0)

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026